Hybio Pharmaceutical Co., Ltd. (SHE:300199)
19.59
-1.47 (-6.98%)
Nov 20, 2026, 3:04 PM CST
| Market Cap | 17.30B +2.4% |
| Revenue (ttm) | 1.53B +69.9% |
| Net Income | 401.86M |
| EPS | 0.44 |
| Shares Out | 883.24M |
| PE Ratio | 44.54 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 27,316,237 |
| Open | 23.15 |
| Previous Close | 21.06 |
| Day's Range | 19.59 - 23.15 |
| 52-Week Range | 16.23 - 27.70 |
| Beta | 0.92 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 27, 2026 |